Simplex Trading, LLC Harmony Biosciences Holdings, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$28.81 - $33.01 $160,442 - $183,832	5,569 New	5,569 $168,000
Q3 2023 Nov 01, 2023	BUY	$31.89 - $39.03 $55,361 - $67,756	1,736 Added 975.28%	1,914 $62,000
Q2 2023 Aug 04, 2023	BUY	$30.5 - $37.4 $5,429 - $6,657	178 New	178 $6,000
Q3 2022 Nov 04, 2022	BUY	$42.06 - $55.45 $757 - $998	18 Added 2.53%	730 $32,000
Q2 2022 Aug 03, 2022	BUY	$33.54 - $52.15 $20,526 - $31,915	612 Added 612.0%	712 $34,000
Q1 2022 May 02, 2022	BUY	$33.14 - $51.13 $3,314 - $5,113	100 New	100 $4,000

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.95B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.